BAYER STRIKES “MAMMOTH” CRISPR DEAL TO BOLSTER CELL AND GENE THERAPY
(Jan 10, 2022) Bayer and Mammoth Biosciences forged a strategic collaboration potentially valued at more than $1 billion. The partnership grants the Germany-based pharma giant access to Mammoth’s CRISPR technology to develop in vivo gene-editing therapies. The companies plan to harness the power of the CRISPR technology across five preselected in vivo indications. While the companies did not disclose all
Continue ReadingBIOSORTIA PHARMACEUTICALS INVITED TO PRESENT NATIONAL BUSINESS INNOVATION FORUM
Dublin, OH (June 2013) – Dublin, Ohio-based Biosortia Pharmaceuticals has accepted the offer to present at the Innovation Forum in New York City on June 27th at the Yale Club. Biosortia, a premier, aquatic natural products company, is building a library of potent, active, and patented compounds with a primary focus on drug discovery in cancer,
Continue ReadingAlgae: The New Pharmacy Factory
Ross O. Youngs and Kurt Dieck of Biosortia Pharmaceuticals speak to a forum at CMC Dublin, Ohio (March 12, 2013) – With up to 20,000 species in a liter of water, the aquatic environment could become the next frontier for drug discovery. What is in the water is earning more respect thanks to a new biotech
Continue Reading